Parenteral Drug Association
Connecting People, Science and Regulation ®
Menu
About PDA
Leadership
Staff
Code of Conduct
Press Pass Request
Chapters
North America
Europe
Asia Pacific
South America
PDA Foundation
PDA Connect
Contact
Help
Search
When autocomplete results are available use up and down arrows to review and enter to select.
Events & Training
Global Event Calendar
PDA Chapter Events
PDA On Demand
Conferences
Connect, Innovate, Transform: Your Gateway to the Future
PDA Week 2024
2024 Annual Student Volunteer Program
Pre-Meeting Hot Topic Breakfast Roundtables
PDA Week 2025
PDA Week 2024 Onsite
2025 PDA Week Archive
PDA/FDA Joint Regulatory Conference 2024
Speaker
Speaker
PDA Pharmaceutical Microbiology Conference 2024
Speaker
PDA Universe of Pre-Filled Syringes and Injection Devices Conference 2024
Speaker
Conferences
PDA Training
Webinars
Resources by Topic
Aseptic Processing & Sterilization Resources
PDA Glossary
PDA Comments
EU Annex 1 Revision
PUPSIT
Biopharmaceuticals and Biotechnology Resources
PDA Glossary
PDA Comments
EU Annex 1 Revision
PUPSIT
Manufacturing Science Resources
PDA Glossary
PDA Comments
EU Annex 1 Revision
PUPSIT
Quality & Regulatory Resources
PDA Glossary
PDA Comments
Regulatory Authorities
PAC iAM
Drug Shortage
Quality Culture
Supply Chain & Outsourcing Resources
Membership
Join or Renew Today
PDA Interest Groups
Upcoming Volunteer Opportunities
Previous Volunteer Spotlights
Membership Directory
About PDA Honor Awards
Technical Advisory Boards
2023 PDA Honor Awards
Publications
Bookstore
PDA Technical Reports
PDA Letter
Standards
PDA Journal
FDA: Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products
26 August, 2020
Home
/
News
In This Section
Source
Site
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/planning-effects-high-absenteeism-ensure-availability-medically-necessary-drug-products-0
Welcome,
|
My PDA Account
Join PDA
Update My Profile
Terms of Use
Privacy Policy
Change My Password
Log Out
Log In
